Amgen Inc SEC filings AMGN
Amgen Inc has 1,000 filings in SEC EDGAR's recent list, going back to May 22, 2018. Its latest annual report, Form ARS, was filed on Mar 31, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 11-K | Employee savings plan report | Jun 11, 2026 | Dec 31, 2025 |
| 11-K | Employee savings plan report | Jun 11, 2026 | Dec 31, 2025 |
| 25-NSE | Delisting notice | Feb 24, 2026 | — |
| 11-K | Employee savings plan report | Jun 12, 2025 | Dec 31, 2024 |
| 11-K | Employee savings plan report | Jun 12, 2025 | Dec 31, 2024 |
| PX14A6G | Filing | Apr 16, 2025 | — |
| 11-K | Employee savings plan report | Jun 21, 2024 | Dec 31, 2023 |
| 11-K | Employee savings plan report | Jun 21, 2024 | Dec 31, 2023 |
| UPLOAD | Letter from the SEC | May 10, 2024 | — |
| CORRESP | Letter to the SEC | Apr 22, 2024 | — |
| UPLOAD | Letter from the SEC | Apr 5, 2024 | — |
| 11-K | Employee savings plan report | Jun 15, 2023 | Dec 31, 2022 |
| 11-K | Employee savings plan report | Jun 15, 2023 | Dec 31, 2022 |
| 11-K | Employee savings plan report | Jun 24, 2022 | Dec 31, 2021 |
| 11-K | Employee savings plan report | Jun 24, 2022 | Dec 31, 2021 |
| 25-NSE | Delisting notice | Feb 7, 2022 | — |
| 11-K | Employee savings plan report | Jun 23, 2021 | Dec 31, 2020 |
| 11-K | Employee savings plan report | Jun 23, 2021 | Dec 31, 2020 |
| SC TO-T/A | Filing | Apr 16, 2021 | — |
| EFFECT | Filing | Apr 15, 2021 | — |
| CORRESP | Letter to the SEC | Apr 13, 2021 | — |
| SC TO-T/A | Filing | Apr 8, 2021 | — |
| SC TO-T/A | Filing | Apr 6, 2021 | — |
| SC TO-T/A | Filing | Mar 22, 2021 | — |
| SC TO-T | Filing | Mar 18, 2021 | — |
| SC TO-C | Filing | Mar 5, 2021 | — |
| SC TO-C | Filing | Mar 4, 2021 | — |
| SC TO-C | Filing | Mar 4, 2021 | — |
| UPLOAD | Letter from the SEC | Feb 18, 2021 | — |
| CORRESP | Letter to the SEC | Feb 9, 2021 | — |
| 25 | Filing | Dec 28, 2020 | — |
| CERT | Filing | Dec 28, 2020 | — |
| 8-A12B | Filing | Dec 28, 2020 | — |
| 11-K | Employee savings plan report | Jun 17, 2020 | Dec 31, 2019 |
| 11-K | Employee savings plan report | Jun 17, 2020 | Dec 31, 2019 |
| PX14A6G | Filing | Apr 15, 2020 | — |
| CT ORDER | Filing | Oct 24, 2019 | — |
| 11-K | Employee savings plan report | Jun 18, 2019 | Dec 31, 2018 |
| 11-K | Employee savings plan report | Jun 17, 2019 | Dec 31, 2018 |
| CT ORDER | Filing | Jun 3, 2019 | — |
| 11-K | Employee savings plan report | Jun 18, 2018 | Dec 31, 2017 |
| 11-K | Employee savings plan report | Jun 18, 2018 | Dec 31, 2017 |
| CT ORDER | Filing | May 30, 2018 | — |
Showing 43 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- AMGN (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Thousand Oaks, CA
- SEC filer status
- Large accelerated filer
- SEC CIK
- 318154
Other Biological Products, (No Diagnostic Substances) companies
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
- Neurocrine Biosciences Inc NBIX
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.